课题基金 / 基金详情

PROTEIN PHOSPHATASE 2A IN TRANSFORMATION BY POLYOMA/SV40

PROTEIN PHOSPHATASE 2A IN TRANSFORMATION BY POLYOMA/SV40
POLYOMA/SV40 转化蛋白磷酸酶 2A
批准号:
3199246
负责人:
Marc C. MUMBY
金额:
$16.89万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-05-06 至 1995-04-30

项目摘要

项目成果

Marc C. MUMBY的其他基金

相似基金

相关文献

中文摘要
翻译
多瘤病毒中、小肿瘤抗原及其免疫原性 小肿瘤抗原SV40与蛋白磷酸酶2A形成复合物的研究 被病毒感染的细胞。多发性肿瘤中T抗原突变体的研究 已经表明,这种交互以及其他几种交互 细胞蛋白质是转化所必需的,但不是充分的。 虽然SV40 Small T本身不能引起转化,但它 通过大T抗原促进转化。目前的证据表明 SV40 Small T的所有生物学效应都是由 与磷酸酶2A的相互作用。我们已经开发出一种重组的 由纯化的磷酸酶2A或其亚单位组成的系统,以及 重组小T细胞与磷酸酶2A在体外形成复合体, 这种相互作用抑制磷酸酶活性的方式类似于 这是由酶中通常存在的B亚基引起的。我们目前的情况 模型认为,小T的生物效应是由于变化 在磷酸酶2A朝向一组选定的底物的活性中, 而2A型活动的总体水平没有重大变化。 本项目将研究SV40小T与病毒的相互作用 蛋白磷酸酶2A及其形成的生化效应 很复杂。我们还将尝试确定潜在的底物,其 磷酸化受这种相互作用的影响。一系列小写T 将准备改变生化和转化的突变体 助手函数。这些突变体将用于重组试验,以 确定小T-磷酸酶相互作用的分子基础。 小T(和小T突变体的生物学效应 属性)上的磷酸酶2A活性将通过一系列 模型衬底。我们还将确定是否去磷酸化 潜在的体内底物包括SV40大T,视网膜母细胞瘤 蛋白质,而p53通过与小T相互作用而改变。这些研究 应该能让我们确定小T对变形的影响 是由于与磷酸酶2A的相互作用。参与其中的一个 细胞交换因子在小T与磷酸酶相互作用中的作用 将对2a进行测试。一种先前描述的生化活性 小T是某些基因的转录激活。我们将确定 小T/磷酸酶2A复合体的潜在底物参与 腺病毒E2和T细胞受体γ链的反式激活 基因,使用体外转录实验。
英文摘要
The middle and small tumor antigens of polyoma virus and the small tumor antigen of SV40 form complexes with protein phosphatase 2A in virally infected cells. Studies with mutants of polyoma middle T antigen have shown that this interaction, along with those of several other cellular proteins, is necessary but not sufficient for transformation. Although not capable of causing transformation by itself, SV40 small T enhances transformation by large T antigen. Current evidence suggests that all of the biological effects of SV40 small T are mediated by interaction with phosphatase 2A. We have developed a reconstituted system consisting of purified phosphatase 2A, or its subunits, and recombinant small T. Small T and phosphatase 2A form complexes in vitro, and this interaction inhibits phosphatase activity in a manner similar to that caused by the B subunit normally present in the enzyme. Our current model proposes that the biological effects of small T are due to changes in the activity of phosphatase 2A toward a selected set of substrates, without a major change in the overall level of type 2A activity. This project will study the interaction of SV40 small T with protein phosphatase 2A and the biochemical effects of formation of this complex. We will also attempt to identify potential substrates whose phosphorylation are influenced by this interaction. A series of small T mutants will be prepared that have altered biochemical and transformation helper functions. These mutants will be used in reconstitution assays to determine the molecular basis for the small T-phosphatase interaction. The effects of small T (and small T mutants with altered biological properties) on phosphatase 2A activity will be tested with a series of model substrates. We will also determine if dephosphorylation of potential in vivo substrates including SV40 large T, the retinoblastoma protein, and p53 is altered by interaction with small T. These studies should allow us to determine if the effects of small T on transformation are due to interaction with phosphatase 2A. The involvement of a cellular exchange factor in the interaction of small T with phosphatase 2A will be tested. A previously characterized biochemical activity of small T is the transactivation of certain genes. We will identify potential substrates of the small T/phosphatase 2A comp involved in trans-activation of the adenovirus E2 and T cell receptor gamma-chain genes, using in vitro transcription assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell cycle regulation by protein phosphatase 2A
  • 批准号:
    7749048
  • 项目类别:
  • 资助金额:
    $31.09万
  • 财政年份:
    2009
  • 负责人:
    Marc C. MUMBY
  • 依托单位:
Cell cycle regulation by protein phosphatase 2A
  • 批准号:
    8204969
  • 项目类别:
  • 资助金额:
    $30.78万
  • 财政年份:
    2009
  • 负责人:
    Marc C. MUMBY
  • 依托单位:
Cell cycle regulation by protein phosphatase 2A
  • 批准号:
    8019096
  • 项目类别:
  • 资助金额:
    $30.78万
  • 财政年份:
    2009
  • 负责人:
    Marc C. MUMBY
  • 依托单位:
PROTEIN PHOSPHATASES--1996 FASEB CONFERENCE
海外基金